Disclaimer: This site has been first put up 15 years ago. Since then I would probably do a couple things differently, but because I've noticed this site had been linked from news outlets, PhD theses and peer rewieved papers and because I really hate the concept of "digital dark age" I've decided to put it back up. There's no chance it can produce any harm now.
| Identifier: | 02ANKARA8635 |
|---|---|
| Wikileaks: | View 02ANKARA8635 at Wikileaks.org |
| Origin: | Embassy Ankara |
| Created: | 2002-11-26 14:58:00 |
| Classification: | UNCLASSIFIED//FOR OFFICIAL USE ONLY |
| Tags: | ETRD KIPR TU |
| Redacted: | This cable was not redacted by Wikileaks. |
This record is a partial extract of the original cable. The full text of the original cable is not available.
UNCLAS SECTION 01 OF 02 ANKARA 008635 SIPDIS TREASURY FOR OASIA STATE FOR EB/TPP/MTA/IPC - JURBAN AND EUR/SE DEPT PLEASE PASS USTR FOR DBIRDSEY/KALVAREZ DEPT PASS PATENT AND TRADEMARK OFFICE USDOC FOR ITA/MAC/DDEFALCO SENSITIVE E.O. 12958: N/A TAGS: ETRD, KIPR, TU SUBJECT: Update on Intellectual Property Protection Summary ------- 1. (SBU) Econoff discussed intellectual property and market access priorities with American pharmaceuticals companies and with the copyright-based industry associations in Istanbul. The drug companies agreed that they need to make the case with the new Turkish Government on data exclusivity. With the objective of refuting GOT and generics producers' arguments that data exclusivity is too expensive to implement, Eli Lilly has prepared detailed estimates of the cost of this policy to the Turkish Government (approximately USD 3 million annually). Organizations representing the motion picture, music and software industries continue to identify enforcement as their main concern. Some interlocutors believe the new government will be more receptive to their concerns, and these industries plan to call on new policymakers in the near future. End Summary. 2. (U) Econoff met with representatives of U.S. pharmaceuticals companies and the U.S. copyright-based industries in Istanbul on November 21 and 22 to discuss developments in intellectual property protection and market access. Econoff met with the pharmaceuticals companies as a group, which included Eli Lilly, Pfizer, Bristol-Myers Squibb, Wyeth, Abbott Laboratories, Merck Sharp & Dohme, Schering Plough, Pharmacia Upjohn, Janssen Cilag (Johnson and Johnson). We also held a group discussion on problems facing the copyright industries with Erol Ozkur, Anti-Piracy Marketing Manager, Microsoft/ Business Software Alliance (BSA); Nasser Ali Khasawneh, Vice President, BSA; Baha Ozyukseler, General Manager, AMPEC/ MPA (film industry); Nilufer Sapancilar, General Manager AMPEC; and Daghan Baydur, Chairman of MSG (composers/songwriters). Econoff met separately with Mehih Ayracman, Sony Music Managing Director and Board Member of MUYAP (Musical Work Producers Society). Drug Companies on Data Exclusivity, Price Discrimination -------------- 3. (U) In their roundtable meeting at the U.S. Consulate on November 21, the pharmaceuticals firms did not, in depth, address the question of reversing GOT cost-saving measures in the health and pension funds favoring reimbursement of generic drugs. The discussion focused primarily on data exclusivity and price controls and how to address these issues with a new GOT. Ahmed Esen, Pfizer's General Manager, and Roberto Giusti, Eli Lilly's General Manager, dominated the discussion. 4. (U) Data Exclusivity: Roberto Giusti and his Corporate Affairs Manager Sebnem Kocaalp made the case that GOT implementation of data exclusivity would cost the Turkish treasury as little as USD 3 million annually in the form of higher reimbursements for pharmaceuticals covered by the health and pension funds, well below the USD 1 billion cost estimate promoted by Turkish generic drugs manufacturers. Lilly presented a detailed in- house analysis to back up its estimate. Other U.S. companies responded very favorably to Lilly's analysis and discussed various options for presenting it to the GOT, including commissioning an independent study through a Turkish university. 5. (U) Price Discrimination: There was less consensus on the need to press the GOT on price controls, and even on whether the controls discriminated against imports. Ahmed Esen, Pfizer's General Manager, argued that the entire system of price controls, for both local and imported drugs, was not transparent and needed reform. He suggested that a study be commissioned to examine the impact of price controls on imported and local products. Giusti contended that current price/margin controls were clearly discriminatory, and noted that the European pharmaceuticals industry association had examined the issue and would report its conclusions in the near future. Roundtable participants were in general agreement that the current margin control system, which encourages companies to inflate costs to obtain government approval for price increases, depresses reported profits and tax payments by the industry. Copyright Industries Focused on Improving Enforcement --------------------------------------------- -------- 6. (U) Representatives of the motion picture, music and software industries maintained that small-scale street sales of pirated material are the leading problem, though they disagreed as to the adequacy of the GOT's response. Microsoft and BSA representatives opined that the recently-formed, multi-agency inspection and control committees for copyright products were functioning well in the Istanbul region, which accounts for two-thirds of Microsoft's sales in Turkey. In a separate meeting, Melih Ayracman, Sony's Managing Director told Econoff that the committees existed largely on paper, and were not equipped with appropriate tools (support staff, vehicles) to fulfill their functions. Ayracman also raised the continuing problem of broadcast piracy. MSG's Chairman told Econoff that delays and sometimes uneven judgements from the Turkish judiciary were a serious barrier. 7. (U) Our interlocutors were cautiously optimistic that the new GOT would take IPR protection seriously, and they discussed making a coordinated approach to key ministers and other officials in the near future. Baha Ozyukseler, of AMPEC, said it would offer to organize a conference for judges and prosecutors on copyright enforcement in the spring. AMPEC pointed out that one of the new government's first appointments was that of Fikret Uccan, formerly Undersecretary in the Culture Ministry, to the position of Undersecretary in the Prime Ministry. Ozyukseler opined that this might raise the profile of IPR issues overall in the next GOT. Comment ------- 8. (SBU) Given the new government's interest in attracting more foreign investment, we intend to emphasize the link between improved IPR protection and U.S. companies' willingness to maintain or increase investments in Turkey. Pearson
Latest source of this page is cablebrowser-2, released 2011-10-04